Stephen J. DiPalma
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen J. DiPalma
Stephen J. DiPalma is recorded as CFO at Foghorn Therapeutics Inc. (FHTX). Foghorn Therapeutics Inc. reported in an 8-K filed January 17, 2024 that Stephen J. DiPalma was appointed interim Chief Financial Officer, effective January 16, 2024.
“On January 16, 2024, the Board of Directors of Foghorn Therapeutics Inc. (the "Company") appointed Stephen J. DiPalma as Treasurer and interim Chief Financial Officer ("CFO"), effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-16–present
-
Foghorn Therapeutics Inc. (FHTX)
SEC 8-K
Current2024-01-16–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Foghorn Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Adrian Gottschalk CEO, Board Member
- Jeff Sacher CFO
- Kristian F. Humer CFO, Chief Accounting Officer
- Ryan D. Maynard CFO
- Ryan Maynard CFO
- Steven Bellon CTO
- B. Lynne Parshall Board Member
- Ian F. Smith Board Member
- Neil J. Gallagher, M.D., Ph.D. Board Member
- Stuart Duty Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.